News
HighRes Biosolutions announces Chinese distributor agreement with Tekon Biotech Ltd.
July 21, 2010
HighRes Biosolutions, the leader in laboratory automation solutions for life science applications, announced today that it has selected Tekon Biotech Ltd., a leading full-service distributor to analytical and research laboratories, as exclusive distributor of its uniquely modular automation technologies to the top laboratories of China, Hong Kong and Taiwan.
HighRes Biosolutions selected by Rigel Pharmaceuticals for modular high-throughput screening automation
July 12, 2010
HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that it will be providing high-throughput screening automation to Rigel Pharmaceuticals, a South San Francisco, California-based clinical-stage drug development company.
HighRes Biosolutions’ Zaayenga wins ISBER Award
June 11, 2010
HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that Andy Zaayenga, Director of Business Development, received the 2010 International Society for Biological and Environmental Repositories (ISBER) Special Service Award in recognition of his dedicated service and exceptional contributions to the organization.
HighRes Biosolutions joins SiLA
May 12, 2010
HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that it has joined the Standardization in Lab Automation (SiLA) consortium.
HighRes Biosolutions fortifies applications team
April 26, 2010
HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that it has hired Chris Pacheco, Ph.D, as Director of Life Science Technologies. Dr. Pacheco joins HighRes from Dr. Susan Lindquist’s lab at the Whitehead Institute for Biomedical Research at MIT.
HighRes Biosolutions Hires Industry Veteran Andy Zaayenga to Lead Business Development
December 21, 2009
Boston, MA -- HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that industry veteran Andy Zaayenga has been hired as Director of Business Development. Andy’s appointment accompanies a period of consistent expansion for HighRes, including new offerings in sample management and increasing focus in biospecimen science.
HighRes Biosolutions Launches NanoCell - the World’s Smallest Modular Robotic System Available for Drug Discovery
June 22, 2009
HighRes Biosolutions, the leader in innovative robotic systems and laboratory devices for private and academic research laboratories, announced the launch of NanoCell, its newest entry into the world of modular robotic equipment used in drug discovery.
Corning Announces Commercial Agreement with HighRes Biosolutions
September 4, 2008
Companies to Cooperate on Next-Generation Medium- to High- Throughput Systems.
HighRes Biosolutions customer Burnham Institute Awarded $97.9 Million NIH Grant to Expand Small-Molecule Screening and Discovery Center
September 2, 2008
HighRes Biosolutions customer Broad Institute awarded nearly $90M grant to develop chemical probes for human biology and disease
September 2, 2008
HighRes Biosolutions expands into Europe
May 6, 2008
FAST growing US life science automation company, HighRes Biosolutions, is expanding into Europe and is opening an office in the UK. HighRes, which was only formed a few years ago, is already the leading automation integrator for the pharmaceutical sector in the US and is busy developing a large suite of laboratory instruments.
The Burnham Institute selects HighRes Biosolutions' MicroCell for high-throughput screening automation
August 20, 2007
HighRes Biosolutions has just signed a major contract to supply the Burnham Institute for Medical Research (Burnham) with specialized equipment for storing and screening large biological libraries. To be installed at the Institute's Lake Nona, Orlando campus, the new three-pod system, the largest of its kind in the industry will fortify Burnham's bi-coastal research and drug discovery efforts, which include research on cancer, neurological diseases, aging, diabetes, and obesity, as well as other diseases.